Clinical Trial Update: A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, and pharmacokinetics of pazopanib eye drops in healthy adults and elderly; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Pazopanib eye drops (pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration, Age-related Macular Degeneration | Phase 1 | Status: COMPLETED